EXC 2049/1: NeuroCure – Comprehensive approaches to neurological and psychiatric disorders – from mechanisms to interventions –
At a glance
Medicine
Basic Research in Biology and Medicine
Neurosciences
DFG Excellence Strategy Cluster
Project description
Disorders affecting the nervous system impose a significant burden on patients and society, yet our understanding of the molecular and pathophysiological mechanisms at play remains limited. To overcome challenges in translating knowledge into clinical advancements, NEUROCURE is introducing a promising and innovative research agenda. This initiative brings together scientists with cutting-edge expertise in diverse research domains and technologies with the potential to revolutionize basic and translational neuroscience. Our primary objective is to bridge the gap between fundamental and clinical neuroscience, and to foster the development of effective therapies and diagnostic tools. To achieve this, we are implementing programs and establishing structures that facilitate collaborations and the exchange of knowledge and methodologies between basic researchers and clinicians. Rather than focusing solely on a particular brain disease, our overarching goal is to unravel shared pathophysiological processes common to various neurological and psychiatric disorders. Our proposal focuses on collaborative projects in three key areas of neuroscience research: development and its disturbances, maintenance of synapses and circuits in health and disease, and aging and age-associated disorders. These research areas will be complemented by digital approaches and specialized modules that support the translational process: the Neuroscience Clinical Research Center will facilitate access to patients with acute and chronic brain disorders, SPARK aims to aid and expedite the translational pipeline to market, while Value and Open Science strengthens the robustness and predictive power of our research. The success and sustainability of our research activities are also supported by structural measures. These include structured research data management, which makes our research results accessible and transparent, career development for early career researchers, initiatives that make our dynamic research environment diverse and inclusive, and communication formats that encourage dialogue with society and public engagement with our research. With our comprehensive set of structures supporting an ambitious research program, we aspire to accelerate the application of advancements in clinical settings and position Berlin at the forefront of international research in translational neuroscience. We expect that the structures we develop here will serve as a blueprint for other scientific institutions around the world.
Principal investigator
01/2019 - 12/2025
Dietmar Schmitz Prof. Dr.
- Charité – Universitätsmedizin Berlin
Participants
- Person
Prof. Dr. rer. nat. Susanne Schreiber
- Computational Neurophysiology
- Person
Prof. Dr. Marina Mikhaylova
- Department of Biology
- Optobiology
- Person
Prof. Dr. Markus Schülke-Gerstenfeld
- Charité – Universitätsmedizin Berlin
- Person
Prof. Dr. Michael Brecht
- Cluster NeuroCure - Towards a Better Outcome of Neurological Disorders
- Person
Prof. Dr. Dr. h. c. Peter Hegemann
- Department of Biology
- Experimental Biophysics
Cooperation partners
- Cooperation partnerUniversityGermany
Charité – Universitätsmedizin Berlin
- Cooperation partnerUniversityGermany
Free University of Berlin
- Cooperation partnerNon-university research institutionGermany
German Center for Neurodegenerative Diseases
- Cooperation partnerNon-university research institutionGermany
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
- Cooperation partnerNon-university research institutionGermany
Max Delbrück Center for Molecular Medicine in the Helmholtz Association
- Cooperation partnerNon-university research institutionGermany
Max Planck Unit for the Science of Pathogens
Subprojects
- ProjectDFG Excellence Strategy Cluster06/2020 - 12/2025
EXC 2049/1: Neurocure Applying RDoC’s Social Processes Domain to Autism and Social Anxiety Disorder: The Role of Neurobiology, Social Stress/Support, Oxytocin, and Immunological Markers
Principal investigator(s): Prof. Dr. Marina Mikhaylova
- ProjectDFG Excellence Strategy Cluster12/2019 - 02/2024
EXC 2049/1: Towards Precision Medicine in Autism Spectrum Disorder (ASD): Neurobiological Mechanisms and Predictors of Cognitive Behavioral Therapy in Adults With High-Functioning ASD (AG Dziobek)
Principal investigator(s): Prof. Dr. rer. nat. Isabel Dziobek